Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1992 3
1993 1
1994 4
1995 5
1996 3
1997 3
1998 7
1999 8
2000 2
2001 7
2002 3
2003 6
2004 8
2005 4
2006 8
2007 8
2008 10
2009 8
2010 8
2011 6
2012 6
2013 7
2014 4
2015 5
2016 9
2017 3
2018 7
2019 7
2020 7
2021 3
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all
Page 1
Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. Obeid M, et al. Among authors: van endert p. Nat Med. 2007 Jan;13(1):54-61. doi: 10.1038/nm1523. Epub 2006 Dec 24. Nat Med. 2007. PMID: 17187072
Beware the algorithm.
van Endert P. van Endert P. Elife. 2021 May 26;10:e69657. doi: 10.7554/eLife.69657. Elife. 2021. PMID: 34037522 Free PMC article.
Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, Mendiboure J, Pignon JP, Jooste V, van Endert P, Ducreux M, Zitvogel L, Piard F, Kroemer G. Tesniere A, et al. Among authors: van endert p. Oncogene. 2010 Jan 28;29(4):482-91. doi: 10.1038/onc.2009.356. Epub 2009 Nov 2. Oncogene. 2010. PMID: 19881547
Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis.
Hamel Y, Mauvais FX, Madrange M, Renard P, Lebreton C, Nemazanyy I, Pellé O, Goudin N, Tang X, Rodero MP, Tuchmann-Durand C, Nusbaum P, Brindley DN, van Endert P, de Lonlay P. Hamel Y, et al. Among authors: van endert p. Cell Rep Med. 2021 Aug 17;2(8):100370. doi: 10.1016/j.xcrm.2021.100370. eCollection 2021 Aug 17. Cell Rep Med. 2021. PMID: 34467247 Free PMC article.
Ecto-calreticulin in immunogenic chemotherapy.
Obeid M, Tesniere A, Panaretakis T, Tufi R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N, Flament C, Ullrich E, de Botton S, Zitvogel L, Kroemer G. Obeid M, et al. Among authors: van endert p. Immunol Rev. 2007 Dec;220:22-34. doi: 10.1111/j.1600-065X.2007.00567.x. Immunol Rev. 2007. PMID: 17979837 Review.
MHC Class I Cross-Presentation: Stage Lights on Sec22b.
Montealegre S, van Endert P. Montealegre S, et al. Among authors: van endert p. Trends Immunol. 2017 Sep;38(9):618-621. doi: 10.1016/j.it.2017.07.002. Epub 2017 Jul 22. Trends Immunol. 2017. PMID: 28743621 Review.
Peptidases trimming MHC class I ligands.
Weimershaus M, Evnouchidou I, Saveanu L, van Endert P. Weimershaus M, et al. Among authors: van endert p. Curr Opin Immunol. 2013 Feb;25(1):90-6. doi: 10.1016/j.coi.2012.10.001. Epub 2012 Oct 19. Curr Opin Immunol. 2013. PMID: 23089230 Review.
Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Tundo GR, Sbardella D, Ciaccio C, Grasso G, Gioia M, Coletta A, Polticelli F, Di Pierro D, Milardi D, Van Endert P, Marini S, Coletta M. Tundo GR, et al. Among authors: van endert p. Crit Rev Biochem Mol Biol. 2017 Oct;52(5):554-582. doi: 10.1080/10409238.2017.1337707. Epub 2017 Jun 21. Crit Rev Biochem Mol Biol. 2017. PMID: 28635330 Review.
Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
Liu P, Zhao L, Loos F, Marty C, Xie W, Martins I, Lachkar S, Qu B, Waeckel-Énée E, Plo I, Vainchenker W, Perez F, Rodriguez D, López-Otin C, van Endert P, Zitvogel L, Kepp O, Kroemer G. Liu P, et al. Among authors: van endert p. Mol Cell. 2020 Feb 20;77(4):748-760.e9. doi: 10.1016/j.molcel.2019.11.004. Epub 2019 Nov 27. Mol Cell. 2020. PMID: 31785928 Free article.
167 results